DEPECA-1 - A Phase II Study to Evaluate a First-line Systemic Therapy With Enfortumab Vedotin Plus Avelumab for Advanced and Metastatic Penile Carcinoma

Clinical trial NCT07110038 · RECRUITING

Trial details

NCT number

NCT07110038

Sponsor

Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest

Status

RECRUITING

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2025-12-16

Primary completion

2029-05-01

Enrollment

25

View on ClinicalTrials.gov